Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning
From MaRDI portal
Publication:1716206
DOI10.1016/j.jtbi.2010.01.023zbMath1406.92335OpenAlexW1980040626WikidataQ51726588 ScholiaQ51726588MaRDI QIDQ1716206
Alberto d'Onofrio, Alberto Gandolfi
Publication date: 4 February 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2010.01.023
Related Items
Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: a dynamic energy budget (DEB) approach, Local controllability and optimal control for a model of combined anticancer therapy with control delays, Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth, Stability of Hahnfeldt angiogenesis models with time lags, Tumour growth control: analysis of alternative approaches, Closed-loop control of tumor growth by means of anti-angiogenic administration, A generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growth, Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers, Tumor Development Under Combination Treatments with Anti-angiogenic Therapies, Effect of treatment on the global dynamics of delayed pathological angiogenesis models
Cites Work
- Unnamed Item
- Unnamed Item
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Regression and regrowth of tumour cords following single-dose anticancer treatment
- A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results
- Critical-point analysis for three-variable cancer angiogenesis models
- On optimal delivery of combination therapy for tumors
- A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs
- Acute leukemia and chemotherapy: A modeling viewpoint
- A mathematical model of breast and ovarian cancer treated with Paclitaxel
- Hopf point analysis for angiogenesis models
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- Drug resistance in cancer chemotherapy as an optimal control problem
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- Comparison of six models of antiangiogenic therapy
- THREE TYPES OF SIMPLE DDE'S DESCRIBING TUMOR GROWTH
- A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
- Simple ODE models of tumor growth and anti-angiogenic or radiation treatment
